The Department of Radiation Oncology. In loving Memory of Penny Slattery ( ) Medical Physics Journal Manager ( )

Size: px
Start display at page:

Download "The Department of Radiation Oncology. In loving Memory of Penny Slattery ( ) Medical Physics Journal Manager ( )"

Transcription

1 The Department of Radiation Oncology In loving Memory of Penny Slattery ( ) Medical Physics Journal Manager ( )

2 The Department of Radiation Oncology Medical Physics Workshop: Editorial Vision and Guidance on Writing and Reviewing Papers Jeffrey F. Williamson, Ph.D. Medical Physics, Editor-in-Chief Shiva K. Das, Ph.D. Medical Physics, Therapy Physics Editor Mitchell M. Goodsitt, Ph.D. Medical Physics, Imaging Physics Editor

3 Tribute to Penny Med Phys, April 2015

4 Outline Jeff Williamson: Editorial vision and status of new initiatives Shiva Das: Guidelines and templates for Referees and Associate Editors Mitch Goodsitt: Writing good scientific papers and responding to critiques

5 The Department of Radiation Oncology Editorial Vision for Medical Physics Update and current status of new initiatives Jeffrey F. Williamson, Ph.D. Virginia Commonwealth University Medical Physics, Editor-in-Chief

6 Outline Core values and mission Recent initiatives and changes to Med Phys operations Outcomes Ongoing initiatives

7 Medical Physics: Core Mission Enhance Medical Physics status as the preeminent forum for exchange of cutting edge medical physics science To identify and publish the best contributions in cutting edge basic science developments with potential for improving patient care clinical translation and validation of previously developed basic science innovations High impact clinical physics innovations that solve a significant clinical problem of broad interest Features of a publishable articles Novelty Generalizable scientific data or conclusion Relevant to significant subset of our readership

8 Vision and Mission Statement Bill Hendee (2005): to continue the Journal s tradition of publishing the very best science that propels our discipline forward and improves our contribution to patient care. The discipline is broad: application of physics concepts and methods to diagnosis and treatment of disease Medical imaging: pyscho-physics, system design, image reconstruction/restoration» X-rays, US, MR, RF, etc. for anatomic, biomechanical, electrical, molecular, and physiological properties Therapy: platform design, optimization, planning, dosimetry, outcome/biology models, imaging for response and guidance» RT, IG surgery, RF/US oblation and thermal therapy Basic research:» Segmentation, registration, feature extraction, voxel labeling» Image quality assessment and dosimetry» Physiology, biology, statistics

9 Editorial Model With growth of journal, Editor s responsibility has evolved into a full-time position Starting January, 2014, a new model Jeff Williamson, Editor-in-Chief (50%) Mitch Goodsitt, Imaging Physics Editor (25%) Shiva Das, Therapy Physics Editor (25%) Transitioning to in-house Board of Associate Editors Currently, 140 members including Editorial Board 74% of new submissions were managed by inhouse AEs

10 Review Process: 2-3 cycles 1. Ms. Received: Editor-in-Chief (EIC) Selects editor (ED) 2. ED preliminary review a. Rejects paper (15%) OR b. Recruits associate Editor (AE) 3. AE manages review a. Solicits reviews from at least 2 referees b. Makes recommendation to ED 4. Editorial Decision a. ED reviews Ref and AE reviews b. Makes decision and communicates to Author c. EIC signs off on ED decision

11 Ms. Processing and Author Interface Penny: the face of the journal for 20 years Author submissions, questions, reminders Very difficult late 2014, early 2015 Penny quite ill or undergoing treatments with sudden and rapid decline in late February Many innovations and QA systems on hold Hundreds of accumulated s and Ms. New model Interim Editorial Assistant: Ania Bukowski (AIPP)» Handles all Ms processing, author queries, review team support Interim Editorial Assistant: Viv Dennis (AAPM)» Editor, WG, editorial board support

12 Review improvements Current Initiatives In-house AE model Improve selectivity & stabilize Journal growth More thorough and uniform reviews Improve efficiency Improve reader experience Smaller more active Editorial Board (now 35) Advise editorial team, formulate policy, serve as AEs Implement initiatives via Working Groups» WG1: Review process efficiency, quality, selectivity» WG2: accessibility, readability, and interactivity» WG3: Data mining and evaluation of Journal quality» WG4: Outreach: Non-MP scientific/ clinical communities

13 We have increased selectivity/quality Use WG3 data to help us focus on what our audience reads and cites Discourage orphan papers that are rarely cited or read Acceptance rate Down to 45-50% from 55% We have reversed unsustainable Growth Increased focus on Best science Widely read guidance, review, and opinion

14 Review Times Median time to final decision: 88 days 1 st cycle review time: up to 42 days 25% > 60 days Median time to acceptance: 163 days from 138

15 Accomplishments Re-engineered many basic processes Improved QC Functioning process for expediting outliers Improved Correspondence and Appeals workflows New decision and invitation templates Capturing inbound s and consultation feature Major audit and evaluation of our editorial processes by Origin, Inc. All submitted papers screened by Ithenticate WG innovations WG1: review template and taxonomy WG2: Review editor position established WG3: DB established WG4: special CT and upcoming particle Tx issues

16 Dilemmas: Efficiency vs. Quality We work intensively with authors to Make poor articles with potential publishable Make acceptable articles into great articles Provide young scientists with apprenticeship in scientific writing We work hard to ensure only the high quality and innovative science gets accepted Downsides 160 days to acceptance including average of 60 days for R0 preparation Sr. scientists may view our approach as excessively critical

17 Innovations Plans for next year Complete Review Editor selection Create new section medical physics curated dataset article New EB Scientific Integrity Subcommittee (SISC)» Detailed SI/ethics standards and adjudication process Develop comprehensive marketing plan Implement Origin report recommendations BAE/GAE training Fewer chasers at smaller intervals Ask AEs to provide up front list of 4 Referees Improved & consistent Author Instructions Nurture more customer-centered culture

18 New Section: Medical Physics Dataset Articles Describe scientifically or clinically valuable openaccess datasets to help authors publish critically reviewed and documented high quality data sets to assist readers in discovering and using large-scale data sets developed by other investigators MPDAs describe the value; scope; conditions of acquisition; known limitations; and data set format No hypothesis testing or generalizable conclusions MPDA requires that the dataset be publically accessible in a recognized and stable data archive

19 New Section: Medical Physics Dataset Articles Examples large series of anonymized patient mammograms with positive or suggestive BIRADS readings and histopathologic diagnoses for CAD algorithm validation Virtual clinical trial datasets: Serial Tx-position CT datasets including validated physician organ segmentations, identified registration landmarks, and nonrigid planning-to-tx registrations Main barrier Lack of accessible dataset repositories for large scale data To date, scientific societies, e.g., AAPM, have stepped forward

20 Conclusion Medical physics research is rapidly changing More multidisciplinary More focus on imaging even in therapy New submission rapidly increasing especially from from Europe and Asia Med Phys needs to adapt, too Faster, more interactive Better understand and serve readership/authorship needs Appreciate our broad international and multidisciplinary audience Improve Med Phys impact and quality while nurturing positive aspects of its culture

In Memory of Alex Turner Medical Physics Workshop: Editorial Vision and Guidance on Writing and Reviewing Papers. Outline

In Memory of Alex Turner Medical Physics Workshop: Editorial Vision and Guidance on Writing and Reviewing Papers. Outline The Department of Radiation Oncology In Memory of Alex Turner Medical Physics Workshop: Editorial Vision and Guidance on Writing and Reviewing Papers Russell B. Tarver, M.S. The Center for Cancer and Blood

More information

The Roles and Task of Medical Physicists in Clinical Trial (Therapy Trials: RTOG and NRG)

The Roles and Task of Medical Physicists in Clinical Trial (Therapy Trials: RTOG and NRG) 1 The Roles and Task of Medical Physicists in Clinical Trial (Therapy Trials: RTOG and NRG) YING XIAO, PHD AAPM Annual Meeting, 2017 NCI National Clinical Trials Network The NCTN structure includes five

More information

Tina Morrison, Ph.D. Chair, Committee on Modeling and Simulation Office of the Chief Scientist U.S. Food and Drug Administration

Tina Morrison, Ph.D. Chair, Committee on Modeling and Simulation Office of the Chief Scientist U.S. Food and Drug Administration Tina Morrison, Ph.D. Chair, Committee on Modeling and Simulation Office of the Chief Scientist U.S. Food and Drug Administration Tina.Morrison@fda.hhs.gov Joseph Pellettiere Overview FDA s Strategic Plan

More information

Making Models Publicly Available: Successes and Challenges

Making Models Publicly Available: Successes and Challenges Making Models Publicly Available: Successes and Challenges Tina Morrison PhD Office of Device Evaluation Center for Devices and Radiological Health U.S. Food and Drug Administration Modeling & Simulation

More information

How to write and publish a scientific paper (in English)

How to write and publish a scientific paper (in English) How to write and publish a scientific paper (in English) Thomas Ferkol, MD Alexis Hartmann Professor of Pediatrics Professor of Cell Biology and Physiology Washington University School of Medicine President

More information

UPICT template structure as modified by QIBA VolCT Technical Committee June 25, 2009

UPICT template structure as modified by QIBA VolCT Technical Committee June 25, 2009 UPICT template structure as modified by QIBA VolCT Technical Committee June 25, 2009 The QIBA VolCT Technical Committee modified and used the UPICT template for a VolCT profile on CT Lung Nodule Volume

More information

SciTechnol Mediakit. MatheMatics. Research and Reports on. Research Journal of Clinical Pediatrics

SciTechnol Mediakit. MatheMatics. Research and Reports on. Research Journal of Clinical Pediatrics SciTechnol Mediakit Research Journal of Clinical Pediatrics Research and Reports on MatheMatics www.scitechnol.com www.scitechnol.com Our Vision To publish, promote and disseminate the work of medical

More information

MOSAIQ. Radiation Oncology Information System. Confidence for you and your patients

MOSAIQ. Radiation Oncology Information System. Confidence for you and your patients MOSAIQ Radiation Oncology Information System Confidence for you and your patients MOSAIQ Radiation Oncology Information System Capture the Entire Oncology Chart in a Single Integrated Solution MOSAIQ is

More information

7/22/2014. The Necessity of Innovation in Medical Physics. Disclosures. AAPM - Medical Physicists. John Bayouth, Ph.D.

7/22/2014. The Necessity of Innovation in Medical Physics. Disclosures. AAPM - Medical Physicists. John Bayouth, Ph.D. The Necessity of Innovation in Medical Physics John Bayouth, Ph.D. President, AAPM Professor and Chief of Physics Department of Human Oncology University of Wisconsin Disclosures Principal employer: University

More information

AI for TB Screening Guide

AI for TB Screening Guide AI for TB Screening Guide With AI for TB software, chest X-rays can automatically be analyzed for signs of tuberculosis. You can access through the web, standalone appliance or integrated into any PACS

More information

Biomedical engineering (BME) is the application of engineering principles and design concepts

Biomedical engineering (BME) is the application of engineering principles and design concepts AIHA Internet Resources Digest Supporting Access to the High Quality Online Resources August 2014 Spotlight on: Resources on Biomedical Engineering Biomedical engineering (BME) is the application of engineering

More information

Rishabh Kapoor Jatinder R. Palta Daniel Yeung Anh Le University of Florida

Rishabh Kapoor Jatinder R. Palta Daniel Yeung Anh Le University of Florida Rishabh Kapoor Jatinder R. Palta Daniel Yeung Anh Le University of Florida Improve the connectivity of various radiation oncology hardware and software products Improve radiation oncology work flow Help

More information

Outline AAPM -- TG-127. TG and ABR. TG Scope Current General Status of MOC in eyes of TG-127 Continuing Education SAMs PQI Summary

Outline AAPM -- TG-127. TG and ABR. TG Scope Current General Status of MOC in eyes of TG-127 Continuing Education SAMs PQI Summary Outline AAPM -- TG-127 Michael Yester, Ph.D. University of Alabama at Birmingham TG - 127 Scope Current General Status of MOC in eyes of TG-127 Continuing Education SAMs PQI Summary TG - 127 Scope The

More information

8/3/2016. Jatinder R Palta PhD Virginia Commonwealth University and National Radiation Oncology Program Veterans Health Affairs Richmond, Virginia

8/3/2016. Jatinder R Palta PhD Virginia Commonwealth University and National Radiation Oncology Program Veterans Health Affairs Richmond, Virginia Jatinder R Palta PhD Virginia Commonwealth University and National Radiation Oncology Program Veterans Health Affairs Richmond, Virginia Virtual simulation, 3D computation & optimization, IMRT, IGRT, MC

More information

SPECTArare as an innovative model of combining clinical research and care in an ERN. Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium

SPECTArare as an innovative model of combining clinical research and care in an ERN. Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium SPECTArare as an innovative model of combining clinical research and care in an ERN Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium Contents The changing clinical research pathway How

More information

Cardinal Health Specialty Solutions. Bringing a new drug to life. Regulatory Sciences

Cardinal Health Specialty Solutions. Bringing a new drug to life. Regulatory Sciences Cardinal Health Specialty Solutions Bringing a new drug to life Regulatory Sciences How we guided a pharma s breakthrough vision to commercial reality The right drug can mean the difference between life

More information

Speed your time to market with FDA s expedited programs

Speed your time to market with FDA s expedited programs Regulatory Sciences Expediting drug approval Speed your time to market with FDA s expedited programs The faster way to marketing submission and drug approval for serious conditions and rare diseases In

More information

8/2/2017. Key attributes of scientific excellence: rigor, innovation, and relevance. Medical Physics 3.0. Key Attributes of Scientific Excellence

8/2/2017. Key attributes of scientific excellence: rigor, innovation, and relevance. Medical Physics 3.0. Key Attributes of Scientific Excellence Medical Physics 3.0 in Design Key attributes of scientific excellence: rigor, innovation, and relevance Maryellen Giger, Ph.D. A. N. Pritzker Professor of Radiology / Medical Physics The University of

More information

Precision in Quantitative Imaging: Trial Development and Quality Assurance

Precision in Quantitative Imaging: Trial Development and Quality Assurance Precision in Quantitative Imaging: Trial Development and Quality Assurance Susanna I Lee MD, PhD Thanks to: Mitchell Schnall, Mark Rosen. Dan Sullivan, Patrick Bossuyt Imaging Chain: Patient Data Raw data

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

Thanks to Jeff Williamson, Mike Steinberg, James Purdy

Thanks to Jeff Williamson, Mike Steinberg, James Purdy Thanks to Jeff Williamson, Mike Steinberg, James Purdy Radiation Therapy 1.6M new cancer cases this year in US Approximately 60% of cancer patients receive radiation therapy during the course of their

More information

Connect and Deliver Optima CT580 RT

Connect and Deliver Optima CT580 RT GE Healthcare Connect and Deliver Optima CT580 RT Taking aim at cancer requires more than skill and compassion it takes the right connections. Radiation oncologists must connect with a CT simulator that

More information

EMRs and Disease Registries for Chronic Disease Care: Technologies and Trade-offs

EMRs and Disease Registries for Chronic Disease Care: Technologies and Trade-offs EMRs and Disease Registries for Chronic Disease Care: Technologies and Trade-offs Walter Sujansky, MD PhD Health Care Information Technology 2004 November 18, 2004 Role of Information Technology in Chronic

More information

Clinical and Translational Research: Expectations and Goals

Clinical and Translational Research: Expectations and Goals Clinical and Translational Research: Expectations and Goals Daniel E. Ford, M.D., M.P.H. Director, Institute for Clinical and Translational Research Vice Dean for Clinical Investigation Clinical Research

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

Biotech Patents in Europe

Biotech Patents in Europe Biotech Patents in Europe Introduction This circular relates to biotech patent practice in Europe. It is based on our experience of drafting and prosecuting biotech applications. The circular is written

More information

Lead the way. Molecular Imaging. GE Healthcare. imagination at work

Lead the way. Molecular Imaging. GE Healthcare. imagination at work 2010 General Electric Company All rights reserved. General Electric Company reserves the right to make changes in specifications and features shown herein, or discontinue the product described at any time

More information

EUROPEAN TECHNOLOGY PLATFORM NANOMEDICINE. Work plan for GA, 16th January 2008

EUROPEAN TECHNOLOGY PLATFORM NANOMEDICINE. Work plan for GA, 16th January 2008 Work plan for 2008 1 Vision In 10 years nanomedicinebased products will lead to breakthroughs in the treatment of diseases such as cardiovascular disease, cancer, CNS diseases and diabetes. 2 The ETP is

More information

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident Resident s Name: RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident Rotation: PHYS 705: Clinical Rotation 3 Inclusive dates of rotation: Aug. 25, 2015 Feb. 25, 2016 Director or Associate

More information

US Department of Health & Human Services, Office of the National Coordinator (ONC), Nationwide Health Information Network (NHIN) Trial Implementations

US Department of Health & Human Services, Office of the National Coordinator (ONC), Nationwide Health Information Network (NHIN) Trial Implementations US Department of Health & Human Services, Office of the National Coordinator (ONC), Nationwide Health Information Network (NHIN) Trial Implementations Update to WVHIN Board of Directors October 9, 2008

More information

Imaging Systems. Gene Saragnese CEO Imaging Systems

Imaging Systems. Gene Saragnese CEO Imaging Systems Growth from the Core: Imaging Systems Gene Saragnese CEO Imaging Systems Imaging g Markets 2009 Imaging Markets by Region Total EUR 14.2B 1700 900 350 1550 2300 Other emerging LATAM India Greater China

More information

03/08/2017. Advances and Challenges in Contour QA for Adaptive RT. Objective. Disclosures

03/08/2017. Advances and Challenges in Contour QA for Adaptive RT. Objective. Disclosures Advances and Challenges in Contour QA for Adaptive RT Kristy K Brock, PhD, DABR, FAAPM Professor, Department of Imaging Physics Director, Image Guided Cancer Therapy Program University of Texas MD Anderson

More information

From Isolation to Insights

From Isolation to Insights From Isolation to Insights Now more than ever healthcare organizations are called upon to deliver increased value at reduced cost. Fostering this level of optimization and continuous improvement requires

More information

EXECUTIVE SUMMARY. Overview of Autoimmune Disease Research

EXECUTIVE SUMMARY. Overview of Autoimmune Disease Research EXECUTIVE SUMMARY REPORT #04-013 June 2004 Price: $2,400 USD Page Count: 162 Overview of Autoimmune Disease Research Overview Each year, hundreds of millions of dollars are devoted to ing the mysteries

More information

ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS

ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS 2018-2024 ORACLE 2.0: Leading Globally, from Innovation to Impact P1 P2 NOTE FROM OUR LEADERS NOTE FROM VP RESEARCH,

More information

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Interview Maximizing the Value of Biospecimens to Deliver New Therapies with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Introduction and Background CLIVE GREEN This ebook originated

More information

The Roadmap Ahead for Big Data in? Radiation Oncology. Conflict of Interest Statement. Oncology Radiation Oncology Medical Physics

The Roadmap Ahead for Big Data in? Radiation Oncology. Conflict of Interest Statement. Oncology Radiation Oncology Medical Physics The Roadmap Ahead for Big Data in Radiation Oncology Sasa Mutic, PhD Professor Vice-chair of Medical Physics and Clinical Strategy Conflict of Interest Statement TreatSafely founder and partner Radialogica

More information

Summary of MRC Unit and Institute Quinquennial Reviews

Summary of MRC Unit and Institute Quinquennial Reviews Summary of MRC Unit and Institute Quinquennial Reviews The MRC carries out scientific reviews in order to be assured of: the overall quality, impact, and productivity (past and future potential) of the

More information

Risk-Based Monitoring Improves Site Performance and Investigator Satisfaction

Risk-Based Monitoring Improves Site Performance and Investigator Satisfaction Insight brief Risk-Based Monitoring Improves Site Performance and Investigator Satisfaction By reading this insight brief, you ll learn how RBM: Leads to earlier insights that improve trial quality Influences

More information

Bravely Addressing Disputed Claims

Bravely Addressing Disputed Claims Bravely Addressing Disputed Claims 2014 Winter Institute & Annual Meeting Indiana Pressler Memorial Chapter of HFMA February 28, 2014 John Woerly, MSA, RHIA, CHAM, FHAM (317)590-3067 john.woerly@accenture.com

More information

What do we need to realize in silico medicine in the future?

What do we need to realize in silico medicine in the future? October 11, 2016 EU Parliament, Brussels What do we need to realize in silico medicine in the future? Modeling and Simulation at U.S. FDA Tina Morrison, Ph.D. Chair, Modeling and Simulation Working Group

More information

Welcome to the 10 th Annual Meeting of ISMPP! Leading Through Collaboration

Welcome to the 10 th Annual Meeting of ISMPP! Leading Through Collaboration Welcome to the 10 th Annual Meeting of ISMPP! Leading Through Collaboration 1 The Medical Publishing Insights and Practices (MPIP) Initiative: A unique collaboration between industry and journal editors,

More information

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE CANCER CENTER SCIENTIFIC REVIEW COMMITTEE The Clinical Scientific Review Committee (SRC) at The Medical College of Wisconsin Cancer Center plays a vital role in protocol review and monitoring to ensure

More information

Bravely Addressing Disputed Claims John Woerly, RHIA, CHAM, FHAM Senior Principal, Accenture

Bravely Addressing Disputed Claims John Woerly, RHIA, CHAM, FHAM Senior Principal, Accenture Bravely Addressing Disputed Claims John Woerly, RHIA, CHAM, FHAM Senior Principal, Accenture Session Outline Session Objectives Defining Disputed Claims Operational Impacts Conceptual Model Organizational

More information

Clinical Trials application process, legislation & guidelines

Clinical Trials application process, legislation & guidelines Clinical Trials application process, legislation & guidelines IMB Clinical Trials Seminar 19 th June 2012 Elaine Breslin MB BCh (NUI), PhD, FRCPI Clinical Assessment Manager 19/06/2012 Slide 1 IMB Mission

More information

GLOBAL Trend and opportunities in drug development

GLOBAL Trend and opportunities in drug development GLOBAL Trend and opportunities in drug development พญ อรณ ต งเผ า Oranee T Daniels MD October 2015 Looking back during last 15 years Drug safety became a focus for both regulators and drug developers.

More information

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure PRMS Disease Site Committee Review Policy PRMS Procedure for Protocol Review by Site Committee

More information

Oncology Billing Specialists

Oncology Billing Specialists Oncology Billing Specialists ONCOLOGY Coding, Billing and Reimbursement EXPERTS When you entrust your medical billing services to RC Billing, you can rest easy knowing the details are handled to allow

More information

Expanded Access to Investigational Imaging Drugs

Expanded Access to Investigational Imaging Drugs Expanded Access to Investigational Imaging Drugs Phillip B. Davis, MD FDA/CDER/ODEIV/DMIP 6/09/2016 1 Overview Expanded Access (EA) Defined Requirements for all EA authorizations Types of EA Individual

More information

Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation.

Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Carolinas Collaborative Pilot RFA Webinar May 8, 2017 Partners Overview

More information

Facilitating the Use of Imaging Biomarkers in Therapeutic Clinical Trials. Michael Graham, PhD, MD President, SNM Co-chair, Clinical Trials Network

Facilitating the Use of Imaging Biomarkers in Therapeutic Clinical Trials. Michael Graham, PhD, MD President, SNM Co-chair, Clinical Trials Network Facilitating the Use of Imaging Biomarkers in Therapeutic Clinical Trials Michael Graham, PhD, MD President, SNM Co-chair, Clinical Trials Network Facilitating the Use of Imaging Biomarkers in Therapeutic

More information

American Association of Pharmaceutical Scientists (AAPS)

American Association of Pharmaceutical Scientists (AAPS) American Association of Pharmaceutical Scientists (AAPS) AAPS, King Street, Alexandria, VA, USA* he American Association of Pharmaceu- Scientists (AAPS), founded in 1986, Ttical is an individual membership

More information

The Promise and Challenge of Adaptive Design in Oncology Trials

The Promise and Challenge of Adaptive Design in Oncology Trials THE POWER OFx Experts. Experience. Execution. The Promise and Challenge of Adaptive Design in Oncology Trials Clinical oncology trials are more complex and time consuming than those in any other therapeutic

More information

Integrating the MR-Linac into Radiation Therapy Practice

Integrating the MR-Linac into Radiation Therapy Practice Integrating the MR-Linac into Radiation Therapy Practice Mikki Campbell MRT(T), MHE Winnie Li MRT(T), MSc UTDRO Evening Journal Club MR-Linac: From Prototype to Clinical January 24, 2019 Objectives To

More information

Implementing Biomedical Informatics Approaches to Facilitate Translational and Clinical Research

Implementing Biomedical Informatics Approaches to Facilitate Translational and Clinical Research Implementing Biomedical Informatics Approaches to Facilitate Translational and Clinical Research Institute of Medicine May 30, 2014 David A. Fenstermacher, Ph.D. Chief Research Information Officer Professor,

More information

COCIR CT Manufacturers Voluntary Commitment Regarding CT Dose 2014 Annual Report

COCIR CT Manufacturers Voluntary Commitment Regarding CT Dose 2014 Annual Report Preamble COCIR CT Manufacturers Voluntary Commitment Regarding CT Dose 2014 Annual Report This 2 nd Annual Report defines the COCIR CT manufacturers voluntary commitment to HERCA as a result of the meeting

More information

While individually rare, orphan diseases are actually collectively common, with an OF ORPHAN DRUG DEVELOPMENT MEETING THE UNIQUE CHALLENGES

While individually rare, orphan diseases are actually collectively common, with an OF ORPHAN DRUG DEVELOPMENT MEETING THE UNIQUE CHALLENGES ELECTRONICALLY REPRINTED FROM JUNE 2017 CLINICAL TRIALS Rare Diseases: MEETING THE UNIQUE CHALLENGES OF ORPHAN DRUG DEVELOPMENT BY MICHAEL F. MURPHY, MD, Ph D While individually rare, orphan diseases are

More information

Roadmap for Managing Multiple CRO Vendors

Roadmap for Managing Multiple CRO Vendors PharmaSUG 2017 - Paper PO27 Roadmap for Managing Multiple CRO Vendors Veena Nataraj, Shire, Lexington, MA Karin LaPann, Shire, Lexington, MA ABSTRACT When working with CROs, the relationship established

More information

On behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic

On behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic Robert J. Beall, Ph.D. President and Chief Executive Officer Cystic Fibrosis Foundation On behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic fibrosis (CF) in the United States,

More information

High Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch,

High Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch, High Profile Publishing in Molecular Biology Hélène Hodak, h.hodak@elsevier.com Marina Ostankovitch, m.ostankovitch@elsevier.com The field of Molecular Biology, inception to current trends Preparing a

More information

Evolution of the Healthcare Contact Center. Session 52, February 12, 2019 Lynne Hildreth, Director of Patient Access, Moffitt Cancer Center

Evolution of the Healthcare Contact Center. Session 52, February 12, 2019 Lynne Hildreth, Director of Patient Access, Moffitt Cancer Center Evolution of the Healthcare Contact Center Session 52, February 12, 2019 Lynne Hildreth, Director of Patient Access, Moffitt Cancer Center 1 Conflict of Interest Lynne Hildreth Has no real or apparent

More information

CGIR V21N1 January, It is an honor and a privilege for us to take on this new role and responsibility as

CGIR V21N1 January, It is an honor and a privilege for us to take on this new role and responsibility as Incoming Editorial Praveen Kumar & Alessandro Zattoni It is an honor and a privilege for us to take on this new role and responsibility as editors-in-chief (EICs) of Corporate Governance: An International

More information

OECI WORKING GROUP HIGHLIGHTS

OECI WORKING GROUP HIGHLIGHTS OECI WORKING GROUP HIGHLIGHTS Pathobiology Mission Statement To create European (molecular) pathology based platforms or environments that enable or improve knowledge transfer and translational research

More information

Medical Imaging Informatics Overview. Dr. Adam CHEE Chief Advocate (Director) 3 rd Nov 2010

Medical Imaging Informatics Overview. Dr. Adam CHEE Chief Advocate (Director) 3 rd Nov 2010 Medical Imaging Informatics Overview Dr. Adam CHEE Chief Advocate (Director) 3 rd Nov 2010 1 About binaryhealthcare binaryhealthcare is a Social Enterprise that strive to improve healthcare (and saving

More information

Editor Guidelines. Ethics Approval and Informed Consent Statements

Editor Guidelines. Ethics Approval and Informed Consent Statements Editor Guidelines Ethics Approval and Informed Consent Statements Editor Guidelines: Ethics Approval and Informed Consent Statements The inclusion of ethics approval and informed consent statements is

More information

CAQH CORE Valuebased Payment (VBP) Webinar Series: Attribution Unlocking Value-based Purchasing s Full Potential, with the National Quality Forum

CAQH CORE Valuebased Payment (VBP) Webinar Series: Attribution Unlocking Value-based Purchasing s Full Potential, with the National Quality Forum CAQH CORE Valuebased Payment (VBP) Webinar Series: Attribution Unlocking Value-based Purchasing s Full Potential, with the National Quality Forum 2019 CAQH, All Rights Reserved. January 17, 2019 2:00 3:00

More information

THE ESSENTIAL ELEMENT of a

THE ESSENTIAL ELEMENT of a THE ESSENTIAL ELEMENT of a Successful Laboratory LabDAQ Laboratory Information System (LIS) is a scalable SOLUTION trusted by thousands of physicians and laboratory professionals every day. Experience

More information

Webinar: Knowledge-based approaches to decreasing clinical attrition rates

Webinar: Knowledge-based approaches to decreasing clinical attrition rates Webinar: Knowledge-based approaches to decreasing clinical attrition rates Speakers: Dr. Richard K. Harrison Gavin Coney Teresa Fishburne May 2018 2 Clarivate Analytics is the global leader in providing

More information

Establishing an Optimal Operational Infrastructure

Establishing an Optimal Operational Infrastructure Establishing an Optimal Operational Infrastructure David Holmes III holmes.david3@mayo.edu Imaging in Clinical Trials Conference March 30 th, 2017 2015 MFMER slide-1 My Background Ph.D. in Biomedical Engineering/Imaging

More information

Materials Technology Institute Strategic Plan for 2011, 2012 and 2013

Materials Technology Institute Strategic Plan for 2011, 2012 and 2013 Materials Technology Institute Strategic Plan for 2011, 2012 and 2013 Final Revision March 2011 TABLE OF CONTENTS About MTI... 1 History of MTI... 1 Scope... 1 Vision... 1 Mission... 1 Values... 2 Benefits

More information

An Integrated Solution to Your Medical Billing & Collection Needs

An Integrated Solution to Your Medical Billing & Collection Needs An Integrated Solution to Your Medical Billing & Collection Needs 12708 Riata Vista Circle Suite A126 Austin, Texas 78727 Phone: (512) 637-2002 Fax: (512) 637-2007 www.ascend-health.com Second in importance

More information

TEXTRUM Proposing a Journal

TEXTRUM Proposing a Journal Publishing for Academics, Scientists, Professionals and Organizations Proposing a Journal providing knowledge to your needs Proposing a Journal providing knowledge to your needs is dedicated to providing

More information

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure PRMS Disease Site Committee Review Policy PRMS Procedure for Protocol Review by Site Committee

More information

IMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS

IMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS 8 th International Workshop IMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS Organized by: International Union Against Cancer (UICC) Center of Molecular Immunology Cuba, November 10-14, 2008 (http://www.uicc.org)

More information

MOLECULAR DIAGNOSTICS TESTING: Industry Overview and SCM Challenges

MOLECULAR DIAGNOSTICS TESTING: Industry Overview and SCM Challenges MOLECULAR DIAGNOSTICS TESTING: Industry Overview and SCM Challenges Alan Wells, Vice President, Diagnostics Laboratory Operations, Life Technologies Mike Crowell, Sr. Director of Supply Chain, Verinata

More information

DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS

DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS 11TH ANNUAL MEETING OF ISMPP DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS April 28, 2015 Hyatt Regency Crystal City Arlington, VA, USA 11TH ANNUAL

More information

PAREXEL ACCESS MANAGED ACCESS PROGRAMS

PAREXEL ACCESS MANAGED ACCESS PROGRAMS PAREXEL ACCESS MANAGED ACCESS PROGRAMS Demands are increasing on biopharmaceutical companies developing treatments for unmet diseases to make them available to select patients even before the drug is labeled,

More information

SWOG

SWOG SWOG http://swog.org Page 1 of 5 pages Original Release Date: July 1985 Departments Affected: All Revision Date: April 2018 Introduction SERIOUS ADVERSE EVENTS The timely reporting of serious adverse events

More information

Introduction DICOM and imaging Replacing film with PACS What is wrong with the scenario? Going beyond DICOM IHE impact: workflow problems

Introduction DICOM and imaging Replacing film with PACS What is wrong with the scenario? Going beyond DICOM IHE impact: workflow problems Extending DICOM to integrated information environments: IHE Steven C. Horii, MD, FACR, FSCAR Department of Radiology University of Pennsylvania Medical Center Disclosure Receive royalties from SPIE for

More information

SOLVING THE PATIENT RECRUITMENT DILEMMA

SOLVING THE PATIENT RECRUITMENT DILEMMA SOLVING THE PATIENT RECRUITMENT DILEMMA Katheryn Shea is Global Biobanking Lead at Brooks Life Sciences. She is an accomplished biobanking expert with 20+ years of industry experience, author of peer-reviewed

More information

Trans NCI Initiatives Role of imaging as an enabling technology

Trans NCI Initiatives Role of imaging as an enabling technology Oncology Co-Clinical Research Resources (Us) to Develop Best Practices for Quantitative (QI) in Mouse Models A Trans-NCI Initiative Larry Clarke, PhD, Branch Chief, CIP DCTD AAPM Meeting July th 0 Trans

More information

Adis Journals Overview

Adis Journals Overview Adis Journals Overview Introduction Adis Rapid Publishing Service Life after publication AdisOnline.com The Adis publishing heritage The Adis Journals brand has evolved over 40 years to become synonymous

More information

Clinical Evaluation of real-time, patient-centric QA using the Delta 4 Discover

Clinical Evaluation of real-time, patient-centric QA using the Delta 4 Discover Clinical Evaluation of real-time, patient-centric QA using the Delta 4 Discover Karl H Rasmussen, Ph.D.. khrasmussen@uthscsa.edu Nema Bassiri bassirin@livemail.uthscsa.edu Division of Medical Physics Cancer

More information

CARESTREAM RIS/PACS SuperPACS Architecture. A Changing Landscape

CARESTREAM RIS/PACS SuperPACS Architecture. A Changing Landscape CARESTREAM RIS/PACS SuperPACS Architecture A Changing Landscape The field of radiology is in a constant state of acceleration and evolution. Each day, you handle an increasing number of exams and diagnostic

More information

Executive Search. Chief Standards Officer

Executive Search. Chief Standards Officer Executive Search Chief Standards Officer Client Overview Sterling Martin Associates has been retained by the Clinical Data Interchange Standards Consortium (CDISC) to search for Chief Standards Officer

More information

social, and population-based research conducted and supported by the National Institutes of Health (NIH). The

social, and population-based research conducted and supported by the National Institutes of Health (NIH). The Statement by the Ad Hoc Group for Medical Research on FY 2015 Appropriations for the National Institutes of Health Submitted for the record on March 28, 2014, to the Subcommittee on Labor, Health and Human

More information

Practice Optimization Package:

Practice Optimization Package: Practice Optimization Package: Maximize the Success of your Practice You want to continue providing your patients optimal care. We can help you do it. In today s environment it takes more than clinical

More information

MARKEY CANCER CENTER STANDARD OPERATING PROCEDURES. SOP No.: MCC Type: Final

MARKEY CANCER CENTER STANDARD OPERATING PROCEDURES. SOP No.: MCC Type: Final Page 1 of 11 MARKEY CANCER CENTER STANDARD OPERATING PROCEDURES SOP No.: MCC-002.03 Type: Final Title: Protocol Review and Monitoring Committee Functional Overview Approval Signature Date MCC Director

More information

CDISC Standards: Current and Future

CDISC Standards: Current and Future CDISC 2010 CDISC Standards: Current and Future CDISC Japan Interchange Tokyo, Japan 20 July 2010 Rebecca D. Kush, PhD President and CEO, CDISC Clinical Research Standards (Content) (Protocol-driven Research;

More information

Applying Technologies Across the End-to-End PV Process to Increase Compliance and Quality

Applying Technologies Across the End-to-End PV Process to Increase Compliance and Quality Applying Technologies Across the End-to-End PV Process to Increase Compliance and Quality 29 Oct 2015 Andrew Rut, Chief Executive Officer, MyMeds&Me Michael Braun-Boghos, Director of Safety Analytics,

More information

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all

More information

Science Strategy

Science Strategy Science Strategy 2017-2019 September 2017 Food Safety Authority of Ireland Science Strategy, 2017-2019 CONTENTS EXECUTIVE SUMMARY 1 THE FSAI SCIENCE STRATEGY 2 SPECIFIC ACTIVITIES TO ACHIEVE THE STRATEGIC

More information

THE IMPACT OF ADR REPORTING ON SAFE USE OF MEDICINES IN SINGAPORE THE 10-YR EXPERIENCE

THE IMPACT OF ADR REPORTING ON SAFE USE OF MEDICINES IN SINGAPORE THE 10-YR EXPERIENCE THE IMPACT OF ADR REPORTING ON SAFE USE OF MEDICINES IN SINGAPORE THE 10-YR EXPERIENCE Dr John Lim Dr John Lim Chief Executive Officer Health Sciences Authority Singapore 13 October 2006 Ms Chan Cheng

More information

Information Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008

Information Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008 Information Technology for Genetic and Genomic Based Personalized Medicine Submitted April 23, 2008 By The Harvard Medical School Partners HealthCare Center for Genetics and Genomics in Partnership with

More information

Optum Performance Analytics

Optum Performance Analytics Optum Performance Analytics A unified health care data and analytics platform Photo to come Dynamic health care market forces, fueled by delivery and payment reform, have posed many new and difficult questions

More information

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1. The Brazilian Archives of Cardiology (Arq Bras Cardiol) is a monthly publication of the Brazilian Society

More information

Optum Performance Analytics

Optum Performance Analytics Optum Performance Analytics A unified health care data and analytics platform Photo to come Optum Performance Analytics Position your organization for success with Optum Performance Analytics Dynamic health

More information

ServiceSPAN: Making Work Centers Work Better PRODUCTIVITY TOOLS SPECIAL. The Navigator for Enterprise Solutions IN MY OPINION CIO INSIGHTS

ServiceSPAN: Making Work Centers Work Better PRODUCTIVITY TOOLS SPECIAL. The Navigator for Enterprise Solutions IN MY OPINION CIO INSIGHTS PRODUCTIVITY TOOLS SPECIAL The Navigator for Enterprise Solutions NOVEMBER 10-2015 CIOREVIEW.COM IN MY OPINION Hugo Vasquez, Deputy CIO, The AES Corporation CIO INSIGHTS James LaPlaine, CIO, AOL, Inc.

More information

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance.

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance. Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Submitted electronically via http://www.regulations.gov RE: Use of Public Human Genetic

More information

Practical Workflow and the Cost of Adaptive Therapy. Rojano Kashani, Ph.D., DABR Washington University School of Medicine March 7, 2015

Practical Workflow and the Cost of Adaptive Therapy. Rojano Kashani, Ph.D., DABR Washington University School of Medicine March 7, 2015 Practical Workflow and the Cost of Adaptive Therapy Rojano Kashani, Ph.D., DABR Washington University School of Medicine March 7, 2015 Disclosures Travel expenses paid by ViewRay Inc. for on-site software

More information